Antiviral drugs in tablet type are presently in advancement in clinical trials, and researchers state they might be on the market within months.At least 3 antiviral drugs for COVID-19 are in scientific trials, with results from those medical trials to be anticipated by late fall or early winter season, according to Carl Dieffenbach, director of the Division of AIDS at the National Institute of Allergy and Infectious Diseases. They are still months away from being approved by the U.S. Food and Drug Administration (FDA). Unlike the three drugs currently being studied, remdesivir can only be provided intravenously to patients ill enough to be hospitalized with the coronavirus, according to the FDA.Related stories about COVID-19: When will children under 12 be able to get the Pfizer vaccine?The Delta alternative symptoms to look out for if you are totally vaccinatedUnvaccinated individuals 11 times more likely to die from COVID, CDC saysWhat ingredients are in the COVID vaccines?Our journalism requires your support.
- CDCs COVID booster shot reversal: Is the Biden administration following the science? – Fox News
- Georgetown says 2 samples reveal norovirus in campus community, nearly 100 exhibiting symptoms – WTOP